These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33321517)

  • 21. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and design of a randomized clinical trial comparing stress reduction treatment to usual cardiac care: the Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) trial.
    Donahue RG; Lampert R; Dornelas E; Clemow L; Burg MM;
    Psychosom Med; 2010 Feb; 72(2):172-7. PubMed ID: 20028832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
    Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The World Trade Center attack: increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City.
    Shedd OL; Sears SF; Harvill JL; Arshad A; Conti JB; Steinberg JS; Curtis AB
    J Am Coll Cardiol; 2004 Sep; 44(6):1265-7. PubMed ID: 15364330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of coronavirus disease 19 outbreak on arrhythmic events and mortality among implantable cardioverter defibrillator patients followed up by remote monitoring: a single center study from the Veneto region of Italy.
    Zorzi A; Mattesi G; Frigo AC; Leoni L; Bertaglia E; De Lazzari M; Cipriani A; Iliceto S; Corrado D; Migliore F
    J Cardiovasc Med (Hagerstown); 2022 Aug; 23(8):546-550. PubMed ID: 35905001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of ventricular arrhythmia events in ischemic heart disease patients with implantable cardioverter-defibrillators.
    Feng T; Zhang S; Chen K; Hua W; Ren X
    J Mater Sci Mater Med; 2015 Oct; 26(10):240. PubMed ID: 26411436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are Atrial High-Rate Episodes Associated With Increased Risk of Ventricular Arrhythmias and Mortality?
    Vergara P; Solimene F; D'Onofrio A; Pisanò EC; Zanotto G; Pignalberi C; Iacopino S; Maglia G; Della Bella P; Calvi V; Curnis A; Senatore G; Biffi M; Capucci A; Parisi Q; Quartieri F; Caravati F; Giammaria M; Marini M; Rapacciuolo A; Manzo M; Giacopelli D; Gargaro A; Ricci RP
    JACC Clin Electrophysiol; 2019 Oct; 5(10):1197-1208. PubMed ID: 31648745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of health care utilization in patients receiving implantable cardioverter-defibrillator therapies: An analysis of the managed ventricular pacing trial.
    Rickard J; Whellen D; Sherfesee L; Peterson BJ; Nahey T; Tang AS; Ellenbogen KA; Cheng A
    Heart Rhythm; 2017 Sep; 14(9):1382-1387. PubMed ID: 28385672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
    Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of arrhythmias in a large cohort of patients with current implantable cardioverter-defibrillators in Spain: results from the UMBRELLA Registry.
    Fontenla A; Martínez-Ferrer JB; Alzueta J; Viñolas X; García-Alberola A; Brugada J; Peinado R; Sancho-Tello MJ; Cano A; Fernández-Lozano I
    Europace; 2016 Nov; 18(11):1726-1734. PubMed ID: 26705555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant Arrhythmias in Patients With COVID-19: Incidence, Mechanisms, and Outcomes.
    Turagam MK; Musikantow D; Goldman ME; Bassily-Marcus A; Chu E; Shivamurthy P; Lampert J; Kawamura I; Bokhari M; Whang W; Bier BA; Malick W; Hashemi H; Miller MA; Choudry S; Pumill C; Ruiz-Maya T; Hadley M; Giustino G; Koruth JS; Langan N; Sofi A; Dukkipati SR; Halperin JL; Fuster V; Kohli-Seth R; Reddy VY
    Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008920. PubMed ID: 33026892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
    Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.
    Hallstrom AP; McAnulty JH; Wilkoff BL; Follmann D; Raitt MH; Carlson MD; Gillis AM; Shih HT; Powell JL; Duff H; Halperin BD;
    J Am Coll Cardiol; 2001 Mar; 37(4):1093-9. PubMed ID: 11263614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.